Det børsnoterede danske biotekselskab Synact vil om kort tid søge om tilladelse til at starte fase 2-forsøg med selskabes gigtmiddel, der bliver større end først planlagt, og det betyder, at selskabet får brug for yderligere kapital.
Synact Pharma har besluttet at udvide omfanget af et forestående klinisk fase 2-forsøg med selskabets lægemiddelkandidat AP1189 mod leddegigt.
Det oplyser Synact i en børsmeddelelse mandag.
Allerede abonnent? Log Ind.
Senior Project Manager, Unilabs 
Brand and Marketing Manager, biomee™ – MC2 Therapeutics Manufacturing Scientist - FUJIFILM Diosynth Biotechnologies 
BRIDGE – Translational Excellence Programme: Call for Outstanding Postdocs and Experienced Mentors interested in Translational Medicine 
Clinical Trial Manager, Clinical Operations - Symphogen 
Trial Start-up Manager specialised in start-up activities to prepare and improve our clinical trials - Novo Nordisk 
Regulatory Affairs Specialist - Contura Trial Project Manager to lead global clinical trials in a time of great change - Novo Nordisk 
Director CMC - Orphazyme 
CMC Regulatory Affairs Manager - Bavarian Nordic 
Senior Manager Business Development - Ascelia Pharma 
QA Projektleder for implementering af SAP S/4 HANA - Nomeco 
Senior Scientist in Molecular Pharmacology - Zealand Pharma 
Senior Manager, QA GMP - Genmab 
Erfaren udstyrskemiker til Aseptic Production, Equipment Team - ALK Senior Sustainability Manager - ALK 
Experienced Scientist - LEO Pharma Medical Doctor - ALK 
International Portfolio Manager - Orifarm Associate CMC Project Manager - Genmab 
CMC Specialist at VarmX BV 
Global Pharmaceutical Expert – Europe, Business Development & Licensing - KHIDI .png)
Head of PR/Communication – MC2 Therapeutics A/S Quality Assurance Specialist - Orifarm Director of Clinical Quality Assurance Operations – Orphazyme 
QA Manager - Ascendis Pharma Manager of Medical Writing - Orphazyme Principal Scientist - Symphogen Global Pharmaceutical Expert – Europe, Regulatory Affairs - KHIDI 
Vice President Global Quality Assurance and Regulatory Affairs – Etac Group Global Sales Manager – MC2 Therapeutics 
Director Pharmacology & New Target Discovery - Y-mAbs Infrastructure Director - Genmab Senior contract Manager - Genmab Senior Medical Writer - Orphazyme Udstyrskemiker til Aseptic Production, Equipment Team – 2 årlig stilling - ALK 
Kvalitetschef, QP/RP til Specific Pharma A/S Pioneering Drug Delivery Expert - LEO Pharma 
